0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-371.70%PremiumDec 20, 2024Expiry Date3.94Intrinsic Value100Multiplier28DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.27Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Cumberland Pharmaceuticals Stock Discussion
Cumberland Pharmaceuticals Receives FDA Orphan Drug and Rare Pediatric Disease Designations for New Treatment of Duchenne Muscular Dystrophy
$SNDL Inc (SNDL.US)$
$Cumberland Pharmaceuticals (CPIX.US)$
$Sonoma Pharmaceuticals (SNOA.US)$
$Ispire Technology (ISPR.US)$
$Veru Inc (VERU.US)$
$Greenlane (GNLN.US)$
$OrganiGram (OGI.US)$
$Cronos Group (CRON.US)$
$GrowGeneration (GRWG.US)$